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T cell emigration from the thymus is essential for immunological homeostasis. While 
stromal cell-produced sphingosine-1-phosphate (S1P) has been shown to promote 
thymocyte egress via the S1P receptor, S1PR1, the significance of S1P/S1PR1 signaling 
in the thymic stromal cells that surround T cells remains unclear. To address this issue, 
we developed conditional knockout mice (Lyve1-CRE/S1pr1f/f mice) in which S1pr1 
was selectively targeted in cells expressing the lymphatic endothelial cell marker, Lyve1. 
In these mice, T cells were significantly reduced in secondary lymphoid tissues, and 
CD62L+ mature CD4 and CD8 single-positive (SP) T cells accumulated in the medulla 
failed to undergo thymus egress. Using a Lyve1 reporter strain in which Lyve1 lineage 
cells expressed tdTomato fluorescent protein, we unexpectedly found that a considerable 
proportion of the thymocytes were fluorescently labeled, indicating that they belonged to 
the Lyve1 lineage. The CD4 and CD8 SP thymocytes in Lyve1-CRE/S1pr1f/f mice exhib-
ited an egress-competent phenotype (HSAlow, CD62Lhigh, and Qa-2high), but were CD69high 
and lacked S1PR1 expression. In addition, CD4 SP thymocytes from these mice were 
unable to migrate to the periphery after their intrathymic injection into wild-type (WT) 
mice. In contrast, WT T cells could migrate to the periphery in both WT and Lyve1-CRE/
S1pr1f/f thymuses. These results demonstrated that thymocyte egress is mediated by 
T cell-expressed, but not stromal cell-expressed, S1PR1 and caution against using the 
Lyve1-CRE system for selectively gene deletion in lymphatic endothelial cells.
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inTrODUcTiOn
Sphingosine-1-phosphate (S1P) is a polar lipid mediator that is intracellularly generated from 
sphingomyelin by the successive actions of ceramidase and the sphingosine kinases, such as Sphk1 
and Sphk2, and is transported out of the cells by S1P transporters, such as Spns2 (1). Because the 
S1P concentrations are much higher in blood and lymph than in the parenchyma of lymphoid tis-
sue, S1P gradients are thought to form between lymph and lymphoid tissues and to mediate the 
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lymphocyte egress from lymphoid tissues via the S1P receptor 
S1PR1, expressed on lymphocytes (2, 3).
The S1PR1 is encoded by the S1pr1 gene in mouse and is a 
G protein-coupled receptor (GPCR) originally identified by its 
involvement in endothelial cell (4). S1PR1 couples mainly to 
Gi/o proteins to induce activation of the Ras–ERK, PI3K–Akt, 
and small GTPases (Rac and Rho) signaling pathways (5). Both 
S1pr1-deficient mice (6) and Tie2-CRE/S1pr1f/f mice (7), in which 
S1pr1 is selectively disrupted in endothelial cells, die during 
embryogenesis due to vascular network abnormalities. S1PR1 is 
also highly expressed in lymphocytes, and as described above, 
lymphocyte-intrinsic S1PR1 is thought to regulate lymphocyte 
egress from the thymus (8–10) as well as from secondary lym-
phoid tissues (9).
Paradoxically, however, S1PR1 activation in vivo is found to 
occur predominantly in the CD31-expressing vascular struc-
tures, and not in the majority of lymphocytes in lymphoid tissues, 
including the thymus, under homeostatic conditions (11). Given 
that thymocytes leave the thymus via blood vessels (10, 12) and 
also lymphatics (12–14), the finding that S1PR1 is activated in 
the thymic vascular endothelial cells suggests that the thymic 
vasculature (blood vessels and lymphatics) may also play a role 
in mediating thymocyte egress to the periphery.
The lymphatic vessel endothelial hyaluronan receptor 1 
(Lyve1) is a type I integral membrane protein bearing a Link 
module that binds hyaluronan, one of the most abundant gly-
cosaminoglycans in the extracellular matrix (15). Lyve1 has been 
shown to bind and internalize hyaluronan (16), and hyaluronan 
binding activates intracellular signaling that promotes lymphatic 
endothelial cell proliferation (17). Since Lyve1-null mice exhibit 
normal lymphatic development and function (18), Lyve1 loss 
may be compensated by other hyaluronan receptors, or the 
function of Lyve1 may be more specific than previously thought. 
Because Lyve1 is expressed by most lymphatic endothelial cells, it 
has been widely used as a lymphatic endothelial-specific marker, 
although its expression has been reported in murine ocular (19) 
and adipose (20) tissue macrophages, murine embryonic blood 
vessel endothelial cells (21), and in human hepatic blood vessel 
endothelial cells (22). More recently, Lee demonstrated that Lyve1 
is expressed in a fraction of hematopoietic stem cells and in blood 
vessel endothelial cells in the mouse yolk sac, suggesting that this 
protein is expressed during hematopoiesis and vascular develop-
ment in mice (23).
Lyve1-eGFP-CRE mice express Cre recombinase and 
enhanced green fluorescent protein (eGFP) under control of 
the Lyve1 promoter (24). Researchers have used these mice for 
the conditional ablation of genes in the lymphatic endothelium 
by crossing them with strains carrying loxP-flanked genomic 
segments of interest (24–26). Here, we developed Lyve1-CRE/
S1pr1f/f mice to investigate the role of S1PR1 signaling in 
lymphatic-dependent thymocyte egress. In these mice, mature 
CD4 and CD8 single-positive (SP) T cells were unable to leave 
the thymus and accumulated in the medulla. Unexpectedly, we 
found that S1PR1 expression was absent in a substantial propor-
tion of the thymocytes, suggesting that Lyve1 may normally be 
expressed in T cells. Tracking the Lyve1 lineage cells by using a 
Lyve1-CRE/R26-Tdtomato reporter strain confirmed that Lyve1 
was expressed in a substantial proportion of peripheral T cells as 
well as in thymocytes, particularly those in the thymic medulla, 
which are thought to emigrate from the thymus (10, 27, 28). 
Intrathymic injection studies confirmed that Lyve1-CRE/S1pr1f/f 
T cells were unable to leave the thymus, whereas WT T cells were 
capable of leaving both the WT and Lyve1-CRE/S1pr1f/f thymuses. 
Thus, our findings suggest that Lyve1 lineage thymocytes migrate 
from the thymus in an S1PR1-dependent manner, whereas the 
S1PR1 signaling in thymic stromal cells appears to be dispensable 
for thymocyte egress. Finally, our results also indicate that cau-
tion should be used when employing the Lyve1-CRE system to 
selectively target genes in lymphatic endothelial cells.
MaTerials anD MeThODs
ethics statement
All mice were housed at the Central Animal Laboratory at the 
University of Turku. The animal experiments were approved 
by the Ethical Committee for Animal Experimentation (under 
license number 5587/04.10.07/2014) in Finland, and they were 
performed according to the 3R-principle and in adherence with 
the Finnish Act on Animal Experimentation (497/2013).
Mice
The B6.129P2-Lyve1tm1.1(EGFP/cre)Cys/J (Lyve1-CRE), B6.129S6(FVB)-
S1pr1tm2.1Rlp/J (S1pr1f/f), B6.Cg-Gt(ROSA)26Sortm14(CAG−tdTomato)Hze/J 
(R26-tdTomato), C57BL6-Tg (CAG-EGFP) 10sb/J (beta-actin-
eGFP), and B6.Cg-Tg(CAG-DsRed*MST)1Nagy/J (beta-actin-
DsRed) mice were purchased from Jackson Laboratory. The 
Lyve1-CRE mice were bred with S1pr1f/f or R26-tdTomato mice 
to generate Lyve1-CRE/S1pr1f/f mice for functional studies 
and to generate Lyve1-CRE/R26-tdTomato mice for imaging 
experiments.
immunohistochemistry
For immunohistochemical analysis of the thymus and lymph 
nodes (LNs), 6-μm thick frozen sections were fixed with acetone 
at −20°C and incubated with Alexa647-conjugated ERTR7 (Santa 
Cruz), Alexa488-conjugated anti-Lyve1 (223322; R&D Systems), 
and rabbit polyclonal anti-S1PR1 antibodies (H60; Santa 
Cruz), followed by incubation with Alexa546-conjugated goat 
anti-rabbit IgG antibody (Life Technologies). The images were 
captured using a confocal microscope (LSM 780; Zeiss). To detect 
Qa-2+ cells and tdTomato+ cells, the thymuses were fixed with 
4% paraformaldehyde and then subsequently embedded in 4% 
low-melting agarose (Lonza) in PBS and cut into 200-μm thick 
sections using a vibratome (VT1200S; Leica). The sections were 
incubated overnight at 4°C in PBS containing 0.1% BSA and 1% 
Triton X-100, and Hoechst 33342 (Life Technologies), Alexa647-
conjugated anti-Qa-2 antibody (695H1-9-9; BioLegend), 
DyLight550-conjugated anti-CD31 antibody (MEC13.3; Novus 
Biologicals), or APC-conjugated anti-CD31 antibody (MEC13.3; 
BioLegend). The images were captured using a spinning disk 
confocal microscope (Intelligent Imaging Innovations) and 
processed using Imaris software (Bitplane). Quantitation of the 
cortical and medullary area of the thymus was performed using 
ImageJ software (National Institute of Health).
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Flow cytometry
Thymocytes and lymphocytes were obtained from the thymus, 
LNs, and spleen by mechanically dissociating the tissues. 
Peripheral blood lymphocytes were isolated using Ficoll-Paque 
PLUS (GE Healthcare). Stromal cells in the thymus and LNs 
were isolated as described previously, with minor modifications 
(29). Briefly, the tissues were digested with 0.8  mg/ml dispase 
(Gibco), 0.2 mg/ml Collagenase P (Sigma), and 0.1 mg/ml DNase 
(Roche). The resulting single-cell suspensions were enriched for 
non-hematopoietic stromal cells by using CD45 microbeads 
(Miltenyi Biotech).
The lymphocytes and stromal-enriched cells were resus-
pended in PBS containing 1 mM EDTA, 2% fetal calf serum, and 
0.1% sodium azide and incubated with the following antibod-
ies: APC-Cy7-conjugated anti-CD4 (GK1.5), PerCP-Cy5.5-
conjugated anti-CD8 (53-6.7), Pacific Blue-conjugated anti-B220 
(RA3-6B2), BV510-conjugated anti-CD62L (MEL-14), FITC-
conjugated anti-CD44 (IM7), PE-Cy7-conjugated anti-CD69 
(H1.2F3), Alexa647-conjugated anti-Qa-2 (695H1-9-9), Pacific 
Blue-conjugated anti-HSA (M1/69), anti-6C10 (SM6C10) (30), 
V450-conjugated anti-CD45 (30-F11), PE-Cy7-conjugated anti-
Gp38 (8.1.1), or APC-conjugated anti-CD31 (MEC13.3), all of 
which were purchased from either BioLegend or BD Biosciences 
except anti-6C10. To detect 6C10, lymphocytes were further 
incubated with phycoerythrin-conjugated goat anti-rat IgM 
antibody (Southern Biotech).
S1PR1 expressed on thymocytes and stromal cells was 
detected, as described previously (31). Briefly, single-cell suspen-
sions were incubated with rat anti-S1PR1 monoclonal antibody 
(40 μg/ml, 713412; R&D Systems) followed by incubation with 
phycoerythrin-conjugated goat anti-rat IgG antibody (Southern 
Biotech).
All flow cytometric data were acquired on an LSR 
Fortessa (BD Biosciences) and analyzed using FlowJo software 
(FlowJo, LLC).
intrathymic injection
CD62L+ CD4+ SP cells were isolated from the thymus using a 
mouse CD4+ T cell isolation kit (StemCell Tech), followed by the 
positive selection of CD62+ cells (Miltenyi Biotech). To label the 
cells, they were incubated with 5 μM CFSE or 5 μM CMTMR 
for 30  min at 37°C in RPMI containing 2% FCS. The cells 
(1 × 106 cells in 10 μl PBS) were then injected into the thymus of 
recipient mice, as described previously, with some modifications 
(32). Young female mice (less than 4 weeks old) were used as the 
recipient mice to control thymus size, and the single-cell suspen-
sion was injected directly through the skin into the thoracic cavity 
immediately above the sternum using a 10-μl Hamilton syringe 
equipped with a 33-gauge needle. Two days after the injection, 
the recipient mice were sacrificed, and the donor-derived cells 
in the thymus, blood, spleen, and LNs were quantified by flow 
cytometry.
adoptive homing assays
Lymphocytes were collected from LNs of beta-actin-eGFP 
mice. The cells (1  ×  107  cells in 200  μl PBS) were then 
intravenously injected into the recipient mice. Twelve hours 
after the injection, the recipient mice were sacrificed, and the 
donor-derived cells in the inguinal LNs were quantified by 
flow cytometry.
Quantitative Pcr analysis
CD62L+CD4+ cells were isolated from the thymus, as described 
above, prior to RNA purification (RNeasy Plus Micro, QIAGEN). 
cDNA was generated using Superscript VILO cDNA synthesis 
kit (Life Technologies) and analyzed by a quantitative TaqMan 
RT-PCR method with the primers and probes designed by Universal 
ProbeLibarary Assay Design Center (Roche). S1pr1 primers; 
forward: CGGTGTAGACCCAGAGTCCT, reverse: AGCTTTT 
CCTTGGCTGGAG, Actb primers; forward: CTAAGGCCAAC 
CGTGAAAAG, reverse: ACCAGAGGCATACAGGGACA. The 
expression values were normalized using Actb expression as 
endogenous controls.
statistical analysis
Differences between groups were evaluated with Student’s t-test 
for single comparisons or one-way ANOVA, followed by post hoc 
Tukey tests for multiple comparisons. The statistical analyses were 
performed using Prism software (GraphPad). A P-value <0.05 
was considered to be statistically significant. Data are presented 
as the mean ± SD unless otherwise indicated.
resUlTs
T cells are substantially reduced in the 
secondary lymphoid Tissues of the 
Lyve1-CRE/S1pr1f/f Mice
While T cell egress from lymphoid tissues has been shown 
to require S1PR1 expression on T cells (8, 9), a recent study 
indicates that S1PR1 activation occurs mainly in the vascular 
structures rather than on the T cells in lymphoid tissues (11). As 
shown in Figure 1, S1PR1 was readily detected immunohisto-
logically in the vascular structures including the blood vessels 
and lymphatics of the thymus and LNs (Figure 1A; Figure S1 
in Supplementary Material), and FACS studies confirmed the 
distinct S1PR1 expression in the blood endothelial cells and 
lymphatic endothelial cells of these tissues (Figures 1B,C). To 
address the functional significance of the lymphatic endothelial 
cell-expressed S1PR1 in lymphocyte egress from lymphoid 
tissues, we developed Lyve1-CRE/S1pr1f/f mice, in which 
S1pr1 was deleted selectively in Lyve1 lineage cells due to 
Cre-mediated excision of the loxP-flanked S1Pr1 allele. The 
S1pr1f/f mice were used as controls. As expected, Lyve1-CRE/
S1pr1f/f mice exhibited a strongly downregulated expression 
of S1PR1 on the lymphatic endothelial cells of the thymus and 
LNs (Figure 1C); however, their lymphatics were morphologi-
cally indistinguishable from those in S1pr1f/f mice (data not 
shown). Lyve1-CRE/S1pr1f/f mice also exhibited a markedly 
reduced S1PR1 expression on blood vessel endothelial cells 
(Figure  1C), suggesting that the Lyve1 promoter is active 
in both lymphatic and blood vessel endothelial cells in the 
thymus.
FigUre 1 | s1Pr1 is expressed in lymphatic endothelial cells of the 
thymus and lns. (a) S1PR1 expression was examined 
immunohistologically in the thymus and LNs. Lyve1-positive lymphatics were 
observed in the vicinity of the cortico-medullary junction (dotted line). C, 
cortex; M, medulla. Bars, 100 μm. (B,c) Flow cytometric analysis of S1PR1 
expression in thymic and LN stromal cells of S1pr1f/f and Lyve1-CRE/S1pr1f/f 
mice. (B) CD45-negative stromal cell populations from the thymus and LNs. 
Lymphatic and blood vessel endothelial cells (LECs and BECs) were identified 
by their expression of Gp38 and CD31. (c) S1PR1 expression in LECs and 
BECs in the thymus and LNs of S1pr1f/f (blue line) and Lyve1-CRE/S1pr1f/f 
mice (red line). Data are representative of two (a) or three (B,c) independent 
experiments.
FigUre 2 | T cells are remarkably decreased in the peripheral 
lymphoid tissues of Lyve1-CRE/S1pr1f/f mice. (a) T and B cell numbers 
in the inguinal LNs (ILNs), spleen, blood, thymus, and bone marrow (BM) of 
S1pr1f/f and Lyve1-CRE/S1pr1f/f mice. DP, CD4+CD8+ double positive cells; 
CD4 or CD8 SP, CD4+ or CD8+ single-positive cells. (B) Numbers of CD4+ 
T cell subsets in the inguinal LNs of S1pr1f/f and Lyve1-CRE/S1pr1f/f mice. 
Naïve, memory, and effector CD4+ T cells were defined as CD62L+CD44−, 
CD62L+CD44+, and CD62L−CD44+, respectively. (c) Migration of WT 
lymphocytes into the LNs of S1pr1f/f and Lyve1-CRE/S1pr1f/f mice. 
Lymphocytes from beta-actin-eGFP mice were injected intravenously into 
recipient mice. After 12 h, the inguinal LNs were collected, and donor-derived 
lymphocytes were quantified by flow cytometry. These data are pooled from 
three independent experiments (n > 4) (a) and are representative of two 
(B,c) independent experiments with three mice per group. These data were 
evaluated by Student’s t-test and represent the mean ± SD (*P < 0.05, 
**P < 0.005, and ***P < 0.0005).
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Analysis of the lymphoid tissues and peripheral blood of 
Lyve1-CRE/S1pr1f/f mice revealed that the number of both CD4+ 
T and CD8+ T cells in the LNs, spleen, and peripheral blood was 
substantially reduced compared with those in S1pr1f/f control 
mice (Figure 2A). In contrast, there was no significant difference 
in the number of B cells between the two groups of mice. Further 
analysis showed that naïve (CD62Lhigh and CD44low) T cells, but 
not memory-type (CD62Lhigh and CD44high) or effector-type 
(CD62Llow and CD44high), T cells were markedly reduced in 
the LN of Lyve1-CRE/S1pr1f/f mice compared to the control 
mice (Figure 2B). Analysis of the lymphocytes in the primary 
lymphoid organs showed that the numbers of CD4+ and CD8+ 
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SP cells in the thymus of Lyve1-CRE/S1pr1f/f mice were signifi-
cantly increased compared to those in S1pr1f/f mice, whereas the 
number of B cells in the bone marrow and CD4+CD8+ double 
positive (DP) cells in the thymus was comparable in the two 
types of mice (Figure 2A).
Because S1PR1 expression was disrupted not only in lym-
phatic endothelial cells but also in blood vessel endothelial 
cells in Lyve1-CRE/S1pr1f/f mice (Figure 1B), we investigated 
whether the marked reduction in naïve T and B cells in the 
peripheral LNs in these mice was due to an impaired ability of 
the high endothelial venules to mediate lymphocyte recircula-
tion. To this end, we performed a lymphocyte adoptive transfer 
assay by intravenously injecting LN lymphocytes from beta-
actin-eGFP mice into either Lyve1-CRE/S1pr1f/f mice or S1pr1f/f 
mice. We then examined the migration of the eGFP+ cells 
into the recipients’ LNs. As shown in Figure  2C, adoptively 
transferred CD4+ T cells, CD8+ T cells, and B cells were found 
in comparable numbers in Lyve1-CRE/S1pr1f/f and S1pr1f/f LNs, 
indicating that S1pr1 deletion in the Lyve1-expressing cells 
did not compromise the ability of high endothelial venules to 
mediate lymphocyte trafficking from blood to lymph. These 
results indicated that S1PR1 deletion in Lyve1-expressing 
cells reduced the number of circulating T  and B cells with-
out affecting high endothelial venule-mediated lymphocyte 
recirculation.
Both cD4+ and cD8+ sP subsets 
expressing Qa-2 at high levels 
are Markedly increased in the Thymic 
Medulla of the Lyve1-CRE/S1pr1f/f Mice
Because naïve T cells were strongly reduced in the LNs of 
Lyve1-CRE/S1pr1f/f mice, we further examined the T cell subsets 
in the thymus of these mice. As described above, although 
the Lyve1-CRE/S1pr1f/f and S1pr1f/f thymuses contained simi-
lar numbers of CD4+CD8+ DP cells, there were modest but 
reproducible increases in the proportion of CD4+ and CD8+ 
SP subsets in the Lyve1-CRE/S1pr1f/f thymus (Figures 2A and 
3A). Among the SP subsets, the CD62LhighCD69high cells, which 
barely detectable in the WT thymus, were easily detected in 
the Lyve1-CRE/S1pr1f/f thymus, while the relatively imma-
ture (CD62LlowCD69high) and mature (CD62LhighCD69low) SP 
subsets were proportionately reduced in Lyve1-CRE/S1pr1f/f 
compared with the S1pr1f/f thymus (Figures  3B,C). The 
increased CD62LhighCD69high CD4+ (Figure  3D) and CD8+ 
SP subsets (data not shown) expressed high levels of Qa-2, 
a cell surface marker that is normally expressed strongly on 
CD69low recent thymic emigrants (33) (Figure  3D), although 
CD62LhighCD69high subsets in S1pr1f/f thymus expressed low 
levels of Qa-2 (Figure  3D), raising the possibility that these 
cells were defective in thymic egress. Consistent with this 
possibility, the Lyve1-CRE/S1pr1f/f mice exhibited markedly 
enlarged thymic medullas (Figures  3E,F). Thus, our results 
indicated that S1PR1 ablation in Lyve1-expressing cells leads 
to a thymic accumulation of SP T cells, possibly due to their 
impaired ability to exit from the thymus.
The Medullary sP subsets in Lyve1-CRE/
S1pr1f/f Mice Phenotypically resemble 
egress-competent Thymocytes in Wild-type 
Mice but lack s1Pr1 expression
We next sought to determine why S1PR1 ablation in Lyve1-
expressing cells resulted in the accumulation of semi-mature 
CD4+ and CD8+ SP T cell subsets in the thymic medulla. As 
shown in Figures  3D and 4A, further analysis indicated that 
these CD62LhighCD69high cells were phenotypically very similar 
to the egress-competent cells of the thymus in that they were 
Qa-2high6C10− HSAlow (33, 34); however, the S1PR1 expression was 
uniformly low or absent in these cells (Figure 4B). Quantitative 
PCR analysis confirmed that S1pr1 expression was strongly 
attenuated in mature SP thymocytes in Lyve1-CRE/S1pr1f/f mice 
(Figure  4C). This was an unexpected finding, because (1) SP 
thymocytes most closely resembling recent thymic emigrants 
(HSAlowCD62LhighQa-2high) normally express very high levels of 
S1PR1 (9, 35) and (2) S1PR1 was deleted selectively in the cells 
that expressed the lymphatic endothelial cell-specific marker, 
Lyve1, in these mice.
a large Proportion of Thymocytes, 
including Those in the Medulla, 
Belong to the lyve1 lineage
The lack of S1PR1 expression in the SP T cell subsets in the 
Lyve1-CRE/S1pr1f/f mice suggested that these cells may belong 
to the Lyve1 cell lineage, consistent with a recent lineage tracing 
study, indicating that a small subset of hematopoietic stem cells 
arise from the Lyve1 lineage cells (23). To determine if the SP 
T cells belong to the Lyve1 cell lineage, we crossed Lyve1-CRE 
mice with the Rosa26-floxed stop-tdTomato (R26-tdTomato) 
mice to generate Lyve1-CRE reporter mice. In these mice, 
the Lyve1 promoter-induced expression of Cre recombinase 
in Lyve1-expressing cells results in excision of a floxed stop 
cassette preceding the tdTomato sequence at the Rosa26 locus, 
leading to intracellular tdTomato fluorescence. As shown in 
Figure  5A, flow cytometric analysis of thymocytes from these 
mice showed strong tdTomato expression in approximately 
half of the CD4+CD8+ DP cells and the CD4+ and CD8+ SP T 
cells, suggesting that a considerable proportion of these cells are 
derived from the Lyve1 lineage. Consistent with this possibility, 
histochemical analysis of thymus revealed that tdTomato was 
expressed in both the thymic cortex and the medulla, with the 
medulla exhibiting much stronger fluorescence than the cortex 
(Figure  5B). Both tdTomato-marked and -unmarked mature 
thymocytes exhibited comparable expression level of CD62L, 
CD69, and S1PR1 (Figures  5C,D). The peripheral LNs and 
spleen also contained large numbers of tdTomato-marked and 
-unmarked T and B cells (Figure 5E), indicating that Lyve1 and 
non-Lyve1 lineage cells emigrate from the primary lymphoid 
tissues to repopulate the peripheral lymphoid tissues. Notably, 
however, we were unable to detect Lyve1 expression on the cell 
surface of the tdTomato-marked cells either immunohistochemi-
cally (Figure 5B) or by flow cytometry (data not shown). These 
FigUre 3 | Mature cD4+ and cD8+ sP cells are accumulated in the Lyve1-CRE/S1pr1f/f thymus. (a) Frequencies of CD4+ and CD8+ SP cells in the thymus 
of Lyve1-CRE/S1pr1f/f and S1pr1f/f mice (n = 5). (B,c) Frequencies of immature (CD62LlowCD69high), mature (CD62LhighCD69low), and CD62highCD69high cells in the 
CD4+ or CD8+ SP subset of S1pr1f/f and Lyve1-CRE/S1pr1f/f mice. Data were pooled from nine mice (c). The data were evaluated by Student’s t-test and represent 
the mean ± SD (**P < 0.005 and ***P < 0.0005). (D) Qa-2 expression in the CD62LlowCD69high, CD62LhighCD69low, and CD62LhighCD69high cells in the CD4+ SP 
populations of the S1pr1f/f and Lyve1-CRE/S1pr1f/f thymuses (n = 3). (e) Immunohistological analysis of the S1pr1f/f and Lyve1-CRE/S1pr1f/f thymuses. Thymus 
sections (200-μm thick) were stained with antibodies against Qa-2 (magenta) and CD31 (yellow), nuclear staining was performed using Hoechst 33342 (blue). Qa-2 
expression was prominent in the thymic medulla. Bars, 500 μm (n = 2). (F) Quantification of the cortical and medullary area in the thymus of Lyve1-CRE/S1pr1f/f and 
S1pr1f/f mice. Sections were cut approximate middle of the thymus, and the medullary area was determined based on Qa-2 staining: S1pr1f/f (n = 6) and Lyve1-
CRE/S1pr1f/f (n = 4). These data were evaluated by Student’s t-test and represent the mean ± SD (*P < 0.05).
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results collectively indicate that Lyve1 is expressed in a large 
proportion of lymphocytes during ontogeny and that, in the 
case of the T cell lineage, both Lyve1 and non-Lyve1 lineage 
lymphocytes seed and emigrate from the thymus to replenish 
the recirculating T cell pool in the periphery.
The sP subsets in the Lyve1-CRE/S1pr1f/f 
Thymus are egress incompetent
To determine whether the increased SP T cell subsets in the 
Lyve1-CRE/S1pr1f/f thymus were egress defective, we performed 
intrathymic adoptive transfer assays (36, 37) using fluorescently 
labeled CD62L+CD4+ SP thymocytes from Lyve1-CRE/S1pr1f/f and 
S1pr1f/f mice. As shown in Figure 6, when a 1:1 mixture of S1pr1f/f 
CD62L+CD4+ SP T cells and Lyve1-CRE/S1pr1f/f CD62L+CD4+ 
SP T cells labeled with CFSE and CMTMR, respectively, were 
cotransferred into the thymus of wild-type (WT) recipients, the 
Lyve1-CRE/S1pr1f/f CD4+ SP T cells were retained in the thymus 
more abundantly than the S1pr1f/f CD4+ SP T cells, and they 
migrated much less readily to the recipient’s LNs than did the 
S1pr1f/f CD4+ SP T cells (Figures  6A,B). Similar results were 
obtained when the fluorescent labels were swapped (data not 
shown), indicating that the fluorescent labels had no effect on 
lymphocyte migration. In contrast, when DsRed-expressing WT 
CD62L+CD4+ SP T cells were adoptively transferred into the 
thymus of Lyve1-CRE/S1pr1f/f or S1pr1f/f mice, their migration 
to the LNs of the two different type of mice was comparable 
(Figure  6C), indicating that S1PR1 expression of the thymic 
blood or lymphatic vasculature is dispensable for thymocyte 
egress. These results collectively demonstrated that Lyve1-CRE/
S1pr1f/f CD4+ SP T cells exhibit defective thymus egress and 
that the T cell intrinsic, but not stromal cell-associated S1PR1 
plays a critical role in T cell emigration from the thymus. Our 
FigUre 4 | Thymocytes accumulating in the thymus of Lyve1-CRE/S1pr1f/f mice resemble egress-competent cells, but lack s1Pr1 expression. (a,B) 
Expression of 6C10 and heat stable antigen (HSA) (a) or S1PR1 (B) in immature (CD62LlowCD69high), mature (CD62LhighCD69low), and CD62LhighCD69high cells of the 
CD4+ SP subset in S1pr1f/f and Lyve1-CRE/S1pr1f/f thymuses. The mean fluorescence intensity was normalized against CD62LlowCD69high cells. 6C10 (n = 3), HAS 
(n = 3), and S1PR1 (n = 3). Data are representative of two independent experiments. These data were evaluated by Student’s t-test and represent the mean ± SD 
(*P < 0.05, **P < 0.005, and ***P < 0.0005). (c) S1pr1 expression in CD4+ CD62L+ thymocytes of S1pr1f/f (n = 3) and Lyve1-CRE/S1pr1f/f (n = 3) thymuses. The 
expression intensity was normalized with the expression level of Actb. Data are representative of two independent experiments. These data were evaluated by 
Student’s t-test and represent the mean ± SD (***P < 0.0005).
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results also suggested that subsets of both T and B cells arise 
from the Lyve1 linage.
DiscUssiOn
The thymus plays an integral role in the production, matura-
tion, and export of T cells to the periphery. Previous studies 
demonstrated that the thymocyte egress occurs via two differ-
ent routes, blood vessels (10, 12) and lymphatics (12–14), and 
that thymocyte egress via blood vessels is critically regulated 
by lymphocyte-intrinsic S1PR1 and pericyte-derived S1P (10). 
However, S1PR1 is also abundantly expressed by lymphatic 
endothelial cells (38) and appears to be activated constitutively in 
lymphatics (11), although S1PR1’s role in lymphatic endothelial 
FigUre 5 | Most of thymic stromal cells and thymocytes belongs to the lyve1 lineage. (a) tdTomato expression in the thymocytes of R26-tdTomato (Cre−) 
or Lyve1-CRE/R26-tdTomato (Cre+) mice. (B) Histological sections of the thymus from Lyve1-CRE/R26-tdTomato reporter mice stained with anti-CD31 (green) and 
anti-Lyve1 (cyan) antibodies, and the Hoechst 33342 nuclear stain (blue). Cre recombinase-mediated tdTomato expression is shown in magenta. Bars: 500 μm. 
(c,D) Expression of CD62L, CD69, and S1PR1 in tdTomato− or tdTomato+ CD4+ SP cells of Lyve1-CRE/R26-tdTomato mice. S1PR1 expression was examined on 
mature CD4+ SP cells. (e) tdTomato expression in the T and B cells in the LNs and spleens of R26-tdTomato (Cre−) and Lyve1-CRE/R26-tdTomato (Cre+) mice. 
n = 3 (a,e) and n = 2 (B–D) per group.
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cells remains unresolved. In the present study, we sought 
to address the S1PR1’s role in lymphatic endothelial cells by 
deleting the S1pr1 gene in Lyve1-expressing cells by generating 
Lyve1-CRE/S1pr1f/f mice. Lyve1 is expressed in a majority of 
lymphatics at the protein level and, hence, has been used as 
a lymphatic endothelial cell marker in a number of previous 
studies (16, 39–43), although its expression in other cell types 
has been reported (19, 21–23).
FigUre 6 | cD4+ sP cells in the Lyve1-CRE/S1pr1f/f thymus are egress-incompetent. (a) Egress of S1pr1f/f or Lyve1-CRE/S1pr1f/f thymocytes from the WT 
thymus. CD62L+ CD4+ SP cells of the S1pr1f/f or Lyve1-CRE/S1pr1f/f thymus were labeled with CFSE or CMTMR, respectively, and cotransferred into the WT 
thymus in equal numbers (1 × 106 cells per mouse) by intrathymic (i.t.) injection. Two days after the injection, the numbers of donor-derived cells in the thymus, 
blood, and LNs of recipient mice were analyzed by flow cytometry. (B) Ratio of Lyve1-CRE/S1pr1f/f CD4+ SP cells (CMTMR) to S1pr1f/f CD4+ SP cells (CFSE) that 
migrated into the WT recipient’s LNs. PLN, peripheral LNs; MLN, mesenteric LNs. Data are representative of two independent experiments with three mice per 
group. (c) Egress of WT thymocytes from the S1pr1f/f or Lyve1-CRE/S1pr1f/f thymus. CD62L+CD4+ SP cells from beta-actin-DsRed mice were injected into the 
S1pr1f/f or Lyve1-CRE/S1pr1f/f thymus. Two days later, the frequencies of DsRed+ cells in the thymus, blood, and LNs were analyzed by flow cytometry. Data are 
pooled from two independent experiments (n = 3 per group) and represent the mean ± SD. Differences between the groups were evaluated by one-way ANOVA (B) 
or Student’s t-test (c) (***P < 0.005).
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Our study showed that the Lyve1-CRE/S1pr1f/f mice exhibited 
marked increases in thymic CD4+ and CD8+ SP T cell subsets 
and enlarged thymic medullas compared with those of control 
S1pr1f/f mice or WT mice. The SP T cells from the mutant 
mice exhibited a mature T cell phenotype (6C10− HSAlow Qa-2+ 
CD62L+), superficially resembling T cells leaving the thymus 
(33); however, they lacked S1PR1 expression, which was previ-
ously reported to be essential for thymocyte egress (9). The 
T cells retained in the Lyve1-CRE/S1pr1f/f thymus also exhibited 
much higher CD69 expression than egress-competent cells (34), 
which was probably due to the lack of S1PR1 expression, since 
S1PR1 signaling is critical for suppressing CD69 surface expres-
sion (9, 44) (Figure S2 in Supplementary Material). The absence 
or paucity of S1PR1 expression in these cells was surprising, 
since we used the Lyve1-CRE system to conditionally disrupt 
S1pr1 in lymphatic endothelial cells. We therefore sought to 
track Lyve1 lineage cells and their descendants by generating 
the Lyve1-CRE/R26-tdTomato mice, in which a red fluorescent 
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protein, tdTomato, is expressed in Lyve1-expressing cells and the 
cells in which Lyve1 has been expressed. When isolated cells from 
the peripheral lymphoid tissues of these mice were examined by 
flow cytometry, reporter gene activation was observed in sub-
stantial proportions of T and B lymphocytes, even though they 
were completely devoid of Lyve1 expression on the cell surface. 
Furthermore, histochemical analysis confirmed the abundance of 
tdTomato-marked cells in the thymus of these mice, particularly 
in the medullary compartments where egress-competent cells 
are thought to mainly reside (33, 34, 45). A majority of the 
tdTomato-marked and -unmarked mature thymocytes expressed 
S1PR1. Collectively, these results strongly suggest that the CD4+ 
and CD8+ SP T cells accumulating in the Lyve1-CRE/S1pr1f/f 
mice are Lyve1 lineage descendants that are devoid of S1PR1 
and therefore unable to undergo thymus egress.
Upon surveying the literature, we found reports describing 
the Lyve1 expression in non-lymphatic endothelial cell lineages 
during ontogeny (21, 23, 46). Of note is a recent study by 
Lee (23) showing that Lyve1 expression first appears in the 
mouse yolk sac at E8.5 and that Lyve1 is detected on the cell 
surface of ~50% of the c-kit+ hematopoietic cell precursors and 
most of the CD31+ hemogenic endothelial cells in the yolk 
sac by E10.5 (23). Lyve1-CRE lineage tracing using Lyve1-CRE/
R26-YFP mice showed that at least 30% of the hematopoietic 
precursors in the fetal liver and adult bone marrow express the 
reporter gene, indicating that they are derived from the Lyve1 
lineage, although Lyve1 protein was not detected on the cell 
surface of bone marrow cells in adult mice. Collectively, these 
data indicate that Lyve1 expression is developmentally regulated 
in hematopoietic cells and that hematopoietic precursor cells 
arise from Lyve1 and non-Lyve1 lineages in mice. Our results 
are consistent with the Lee’s finding (23) and extend them 
by showing that a significant proportion of thymocytes and 
peripheral T cells are derived from the Lyve1 cell lineage and 
that thymocytes of this lineage in Lyve1-CRE/S1pr1f/f mice fail to 
leave the thymus due to the absence of S1PR1 expression. Thus, 
our study verifies that cell exit from the thymus is mediated by 
thymocytes’ S1PR1 expression by using a completely different 
model system from that described in previous studies (9, 10). 
Although our study do not support the involvement of S1PR1 
on thymic stromal cells in the regulation of thymocyte egress, 
future work involving the use of conditional knockout mice in 
which S1pr1 is postnatally deleted in the thymic stromal cells 
should clarify this issue.
The biological significance of the Lyve1+/Lyve1− T cell line-
ages is currently unclear. Flow cytometric analysis of the two 
populations showed that their phenotypes were comparable, 
and histochemical analysis indicated that they were randomly 
distributed in peripheral lymphoid tissues (data not shown). 
The finding that T and B cells in the LNs and spleen consisted 
of tdTomato-marked and -unmarked populations suggests that 
lymphocytes descending from both Lyve1 and non-Lyve1 line-
ages have the ability to emigrate from the respective primary 
lymphoid tissues to repopulate the peripheral lymphoid tissues. 
Further investigation is required to understand the biological 
significance of Lyve1 expression in the lymphocyte lineage.
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